AC Immune S.A. (ACIU)
NASDAQ·Healthcare·Biotechnology
$3.02
+6.34%
Mkt Cap $287.72M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 13, 2026 | $1.45M | $426.35K | -70.50% | -$0.19 | -$0.18 | +5.26% | — | — |
| Q4 2025 Nov 4, 2025 | $1.14M | $1.18M | +3.22% | -$0.22 | -$0.20 | +9.09% | — | — |
| Q3 2025 Aug 5, 2025 | $315.78K | $1.64M | +420.50% | -$0.20 | -$0.25 | -25.00% | — | — |
| Q2 2025 Apr 30, 2025 | $473.67K | $1.16M | +145.43% | -$0.22 | -$0.21 | +4.55% | — | — |
| Q1 2025 Mar 13, 2025 | $819.45K | $1.25M | +52.78% | -$0.21 | -$0.18 | +14.29% | — | — |
| Q4 2024 Nov 5, 2024 | $1.39M | $29.69M | +2036.14% | -$0.20 | $0.05 | +125.00% | — | — |
| Q3 2024 Aug 6, 2024 | $101.03M | $766.74K | -99.24% | $0.42 | -$0.25 | -159.52% | — | — |
| Q2 2024 May 13, 2024 | $6.05M | — | — | -$0.15 | -$0.21 | -40.00% | — | — |
| Q1 2024 Mar 14, 2024 | $11.43M | $17.30M | +51.34% | -$0.07 | -$0.06 | +14.29% | — | — |
| Q4 2023 Nov 3, 2023 | $25.99M | — | — | -$0.02 | -$0.20 | -754.34% | — | — |
| Q3 2023 Aug 4, 2023 | $1.90M | — | — | -$0.22 | -$0.22 | +0.00% | — | — |
| Q2 2023 Apr 28, 2023 | — | — | — | -$0.24 | -$0.23 | +4.17% | — | — |
| Q1 2023 Mar 16, 2023 | $1.74M | $1.08K | -99.94% | -$0.28 | -$0.24 | +14.29% | — | — |
| Q4 2022 Oct 28, 2022 | $354.38K | $4.00M | +1028.13% | -$0.24 | -$0.17 | +29.17% | — | — |
| Q3 2022 Jul 28, 2022 | — | — | — | -$0.24 | -$0.24 | +0.00% | — | — |
| Q2 2022 Apr 28, 2022 | $379.05K | — | — | -$0.23 | -$0.25 | -8.70% | — | — |
| Q1 2022 Mar 22, 2022 | $30.80M | — | — | $0.10 | -$0.28 | -380.00% | — | — |
| Q4 2021 Nov 8, 2021 | $30.36M | — | — | -$0.29 | -$0.24 | +17.24% | — | — |
| Q3 2021 Aug 4, 2021 | — | — | — | -$0.22 | -$0.29 | -31.82% | — | — |
| Q2 2021 Apr 28, 2021 | $1.40M | — | — | -$0.21 | -$0.25 | -19.05% | — | — |